Reviews & Analysis

Filter By:

Year
  • Several studies in 2019 have provided exciting insights into the relationship between the immune response to infection and the host metabolic system.

    • Janelle S. Ayres
    Year in Review
  • In this Year in Review, Donna Farber discusses some of the exciting breakthroughs that occurred in the T cell field in 2019, highlighting the therapeutic implications for our understanding of T cell function in infection, allergy, inflammatory disease and cancer.

    • Donna L. Farber
    Year in Review
  • Organoid technology has emerged as a powerful tool to maintain epithelial cells in a near-native state that can be used to better understand the interactions between epithelial cells and the immune system in tissue development, homeostasis, infection and cancer.

    • Yotam E. Bar-Ephraim
    • Kai Kretzschmar
    • Hans Clevers
    Review Article
  • Immune cells and neural cells interact in numerous tissues and organs and can have local and far-reaching physiological effects. Understanding these intimate bidirectional interactions is providing insight into the gut–brain axis, as well as the maternal gut–fetal brain axis.

    • Jun R. Huh
    • Henrique Veiga-Fernandes
    Review Article
  • The authors discuss the formation of two main ‘walls’ of B cell memory to protect against pathogen reinfection. The first wall comprises high-affinity antibodies produced by long-lived plasma cells, while the second wall is formed by memory B cells.

    • Munir Akkaya
    • Kihyuck Kwak
    • Susan K. Pierce
    Review Article
  • Clearing away dead cells — a process known as efferocytosis — is crucial for normal tissue homeostasis and is impaired in several pathological processes. This Review describes new insights into how efferocytes deal with the engulfed dead cell cargo, how efferocytosis supports the resolution of inflammation and how this understanding is informing new therapeutic strategies.

    • Amanda C. Doran
    • Arif Yurdagul Jr
    • Ira Tabas
    Review Article
  • Studies in the field of inflammation in 2019 have highlighted a counterbalancing homeostatic function for the glycolytic metabolite lactate, which is produced in hypoxic conditions, such as in tumours and chronic inflammation. Lionel Ivashkiv describes how lactate suppresses inflammatory signalling pathways and regulates macrophage polarization.

    • Lionel B. Ivashkiv
    Year in Review
  • Therapies based on adoptive cellular transfer of regulatory T (Treg) cells are currently undergoing clinical trials for autoimmune diseases, graft-versus-host disease and the prevention of transplant rejection. This Review provides an overview of Treg cell biology and discusses the latest approaches to enhance Treg cells for therapeutic purposes.

    • Caroline Raffin
    • Linda T. Vo
    • Jeffrey A. Bluestone
    Review Article
  • In 2019, single-cell sequencing studies provided important insight into the diverse gene expression profiles of tissue macrophages, and new systems for specifically deleting macrophages were reported. A lactate ‘timer’ that controls inflammatory responses in macrophages was also described.

    • Peter J. Murray
    Year in Review
  • This Review by Handel and colleagues focuses on how simulation modelling can be used to interrogate the immune system. The authors provide an overview of different model types and encourage immunologists to build their own models.

    • Andreas Handel
    • Nicole L. La Gruta
    • Paul G. Thomas
    Review Article
  • Recent studies using single-cell genomic technologies and in vivo fate mapping have shown that thymic epithelial cells are far more heterogeneous than previously thought, comprising multiple subpopulations with distinct molecular and functional characteristics.

    • Noam Kadouri
    • Shir Nevo
    • Jakub Abramson
    Review Article
  • Single-cell sequencing studies in 2019 have led to exciting discoveries relevant to the roles of the immune system in development, homeostasis and disease.

    • Cecilia Domínguez Conde
    • Sarah A. Teichmann
    Year in Review
  • In the past year, researchers have gained a deeper understanding of the interactions between immune cells and microbially derived metabolites. Wendy Garrett describes the new insights into the receptors, immune cells and pathways triggered by microbial metabolites.

    • Wendy S. Garrett
    Year in Review
  • Several studies from 2019 have highlighted emerging routes of communication between tissue-resident immune cells and local neurons, stromal cells, endothelial cells and epithelial cells to exert effects beyond the local tissue.

    • Ari B. Molofsky
    • Richard M. Locksley
    Year in Review
  • As we age, haematopoiesis becomes skewed towards myelopoiesis. Studies of haematopoietic stem cells (HSCs) transplanted into irradiated recipient mice imply that HSC defects are responsible for this ageing effect. Here, the authors urge caution when using irradiated mice to study haematopoiesis ageing, and propose instead that age-related changes in the bone marrow environment and in downstream progenitors, not just HSCs, may also be responsible for myeloid skewing.

    • Kenneth Dorshkind
    • Thomas Höfer
    • Hans-Reimer Rodewald
    Perspective
  • New approaches to vaccine development have generated exciting results over the past 18 months. Focusing on respiratory syncytial virus infection, influenza and tuberculosis, Fauci and Mascola discuss the impact of structure-based vaccine design, gene-based vaccine platforms and advances in adjuvant development.

    • John R. Mascola
    • Anthony S. Fauci
    Year in Review
  • The gasdermin family of proteins has the capacity to form pores in the membrane, causing a pro-inflammatory lytic type of cell death called pyroptosis, This Review provides a comprehensive overview of the gasdermin family, the mechanisms that control their activation and their role in inflammatory disorders and cancer.

    • Petr Broz
    • Pablo Pelegrín
    • Feng Shao
    Review Article
  • The co-inhibitory receptor TIM3 can serve as a marker of exhausted T cells. Here, the authors investigate the biology of TIM3, discussing its various ligands, signalling pathways and association with human disease. They also provide an overview of emerging clinical data regarding its potential as an anticancer target in combination with PD1 blockade.

    • Yochai Wolf
    • Ana C. Anderson
    • Vijay K. Kuchroo
    Review Article
  • This Review focuses on the cytomegaloviruses and the sophisticated strategies they have evolved to evade immune recognition. The authors suggest a better appreciation of these pathways could have clinical implications beyond antiviral immunity, for instance in understanding immune evasion in cancer.

    • Richard Berry
    • Gabrielle M. Watson
    • Jamie Rossjohn
    Review Article